Abstract 1816: Phenogenomic characterization of immunomodulatory purinergic signaling in glioblastoma
Shannon Coy(Brigham and Women's Hospital), Sandro Santagata(Harvard University), Jaeho Hwang(Brigham and Women's Hospital), Philipp Euskirchen(Humboldt-Universität zu Berlin), Patrick Y. Wen(Dana-Farber Cancer Institute), Nathalie Y.R. Agar(Texas Endosurgery Institute), Prasidda Khadka(Broad Institute), Rumana Rashid(Brigham and Women's Hospital), Jia‐Ren Lin(Harvard University), Sylwia A. Stopka(Brigham and Women's Hospital), Peter K. Sorger(Harvard University Press), Mehdi Touat(Broad Institute), Pratiti Bandopadhayay(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Shu Wang(Chinese Academy of Sciences), Keith L. Ligon(Brigham and Women's Hospital)
Cited by 0
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k